Skip to Main Content

Paper Details

A genetics-led approach defines the drug target landscape of 30 immune-related traits.
Nat Genet
123
2019
immune, immune-mediated disease, patient
Author NameAffiliation
Hai FangUniversity of Oxford
Silva KaselaInstitute of Genomics, University of Tartu
Christopher A O'CallaghanUniversity of Oxford
Christopher A O'CallaghanNIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
Lili MilaniInstitute of Genomics, University of Tartu
Julian C KnightUniversity of Oxford
Julian C KnightNIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
  • 1 - 7

Datasets

Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink
Priority indexDrug targets for immune-mediated diseasesLink